Emerging treatments for recurrent prostate cancer

Area of Science:

• Oncology
• Urology

Background:

• Prostate cancer recurrence affects many men despite radical treatment.
• New therapeutic strategies are emerging for prostate cancer.
• Men with recurrent prostate cancer are often excluded from clinical trials.

Purpose of the Study:

• To review novel therapies for men with recurrent prostate cancer.
• To discuss treatment approaches for local, metastatic, and M0 recurrence.
• To highlight the need for better evidence in recurrent prostate cancer management.

Main Methods:

• Literature review of salvage treatments for recurrent prostate cancer.
• Analysis of emerging therapies for different recurrence patterns.
• Discussion of evidence gaps and future research directions.

Main Results:

• Salvage treatments are available for local recurrence confined to the prostate.
• Therapies for metastatic recurrence are evolving.
• Management of rising prostate-specific antigen (PSA) without demonstrable disease (M0) is discussed.

Conclusions:

• Advances in prostate cancer treatment offer new options for recurrent disease.
• Addressing evidence gaps is crucial for optimizing care for recurrent prostate cancer patients.
• Further research is needed to guide treatment decisions in this population.